ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 안근 마비 시장 규모는 향후 수년간 급성장이 예상됩니다. 예측기간의 성장은 신경질환 유병률 상승, 고령화 인구 증가, 안구운동 장애에 대한 의식 상승, 의료비 증가, 주요 기업에 의한 의료에 대한 투자 증가, 당뇨병이나 고혈압 환자 인구 증가 등에 기인하고 있습니다.
신경 질환의 이환율 증가는 안근 마비 시장의 성장을 견인할 것으로 예측됩니다. 이 질환의 유병률이 상승하고 있는 배경에는 알츠하이머병이나 파킨슨병 등의 질환에 걸리기 쉬워지는 유전적 요인, 신경 변성이나 인지 기능 저하의 원인 하는 식생활의 교란, 운동 부족, 만성적인 스트레스 등의 라이프 스타일의 변화가 있습니다. 2023년 3월, 미국을 거점으로 하는 비영리단체인 Alzheimer's Association은 65세 이상의 미국인 중 670만명이 알츠하이머형 치매를 앓고 있다고 보고했고, 이 수는 2060년까지 1,380만명으로 증가할 것으로 추정하고 있습니다.
안근 마비 시장의 성장은 자가면역 질환의 유병률 증가에 의해서도 추진되고 있습니다. 이러한 질병은 면역계가 기능부전에 빠지기 쉬운 유전적 요인과 감염증, 스트레스, 생활습관 등의 환경적 요인이 결합되어 보다 일반적으로 되어 왔습니다. 2024년 11월, 독일을 거점으로 하는 단체 Versorgungsatlas.de는 2022년에 7,324만 1,305명의 피보험자 중 630만 4,340명이 적어도 하나의 자가면역질환으로 진단되었으며, 유병률은 8.61%로 보고했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 안근 마비 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 안근 마비 시장 : 성장률 분석
세계의 안근 마비 시장 실적 : 규모와 성장, 2019-2024년
세계의 안근 마비 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 안근 마비 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 안근 마비 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
외안근 마비
핵간 안근 마비
세계의 안근 마비 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
수술
약 치료
세계의 안근 마비 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 안근 마비 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 안근 마비 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
안근 마비 시장 : 경쟁 구도
안근 마비 시장 : 기업 프로파일
Hoffmann-La Roche Ltd.
AbbVie Inc.
Novartis AG
Medline Industries Inc.
Regeneron Pharmaceuticals Inc.
제31장 기타 주요 기업 및 혁신 기업
Carl Zeiss AG
Bausch Health Companies Inc.
Sun Pharmaceutical Industries Limited
Bayer AG
Santen Pharmaceutical Co. Ltd.
Oculis Holding AG
Innovative Pharmaceuticals Pvt. Ltd.
Clearside Biomedical Inc.
Altacor Limited
Azura Ophthalmics Ltd.
ViGeneron GmbH
Amritt Inc.
GenSight Biologics SA
EyeBio Inc.
Opthea Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
안근 마비 시장(2029년) : 새로운 기회를 제공하는 국가
안근 마비 시장(2029년) : 새로운 기회를 제공하는 부문
안근 마비 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Ophthalmoplegia refers to the paralysis or weakness of one or more muscles responsible for eye movement. This condition can affect both voluntary and involuntary eye movements and may be caused by neurological disorders, muscle diseases, or vascular conditions.
The main types of ophthalmoplegia include external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia involves the paralysis or weakness of the extraocular muscles, leading to impaired eye movement and drooping eyelids. It is treated with surgery or drug therapy, and the treatments are utilized by end-users such as hospitals, clinics, and ambulatory care centers.
The ophthalmoplegia market research report is one of a series of new reports from The Business Research Company that provides ophthalmoplegia market statistics, including the ophthalmoplegia industry global market size, regional shares, competitors with the ophthalmoplegia market share, detailed ophthalmoplegia market segments, market trends, and opportunities, and any further data you may need to thrive in the ophthalmoplegia industry. This ophthalmoplegia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ophthalmoplegia market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth during the historic period can be attributed to the rising prevalence of neurological disorders, the expanding aging population, the growth of specialty clinics and hospitals, increasing demand for early diagnosis and treatment, a higher number of clinical trials, and greater healthcare insurance coverage.
The ophthalmoplegia market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth during the forecast period can be attributed to the rising prevalence of neurological disorders, an increasing aging population, growing awareness of eye movement disorders, higher healthcare expenditure, increased investment in healthcare by key players, and a growing patient population with diabetes and hypertension. Key trends during this period include advancements in diagnostic technologies, the development of novel therapeutic approaches, strategic collaborations and partnerships, technological innovations in eye tracking devices, and the development of muscle-strengthening drugs.
The increasing incidence of neurological disorders is expected to drive the growth of the ophthalmoplegia market. Neurological disorders affect the nervous system, including the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, coordination problems, and cognitive difficulties. The rising prevalence of these disorders is linked to genetic factors, which make individuals more vulnerable to conditions such as Alzheimer's and Parkinson's disease, as well as lifestyle changes such as poor diet, lack of physical activity, and chronic stress, all of which contribute to neurodegeneration and cognitive decline. Ophthalmoplegia plays a role in diagnosing neurological disorders such as Alzheimer's, multiple sclerosis, and stroke by identifying impaired eye muscle control, which indicates dysfunction in the nervous system. For example, in March 2023, the Alzheimer's Association, a U.S.-based nonprofit organization, reported that 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with projections estimating this number to rise to 13.8 million by 2060. As a result, the increasing prevalence of neurological disorders is contributing to the growth of the ophthalmoplegia market.
The growth of the ophthalmoplegia market is also being fueled by the rising prevalence of autoimmune conditions. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy cells, leading to inflammation and tissue damage. These diseases are becoming more common due to genetic factors that make some individuals more prone to immune system dysfunction, combined with environmental triggers such as infections, stress, and lifestyle factors. Ophthalmoplegia can be particularly helpful in diagnosing autoimmune disorders, as it helps identify underlying immune system issues and allows for targeted treatments that address both the muscular paralysis and the autoimmune condition. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, 6,304,340 of the 73,241,305 insured individuals were diagnosed with at least one autoimmune disease, resulting in a prevalence rate of 8.61%. Consequently, the rising prevalence of autoimmune conditions is driving the growth of the ophthalmoplegia market.
The increasing number of head injuries or trauma cases is expected to further propel the ophthalmoplegia market. Head injuries or trauma refer to damage to the scalp, skull, or brain caused by external forces such as falls, accidents, or impacts. These injuries are becoming more common due to factors such as the rise in road accidents, with high-speed collisions, lack of helmet use, and reckless driving contributing to an increased risk of severe head injuries. Other factors such as workplace accidents, falls, sports injuries, and violence also contribute to the growing incidence of traumatic brain injuries. Ophthalmoplegia can help assess head injuries or trauma by detecting potential neurological damage through impaired eye movement, which allows for early diagnosis and intervention. For instance, in 2023, a report by the Wisconsin Department of Health Services, a U.S. government agency, showed a 3% increase in traumatic injuries caused by assault compared to 2022, with cases rising from 1,544 in 2022 to 1,584 in 2023. As such, the increasing cases of head injuries and trauma are driving the growth of the ophthalmoplegia market.
Major players in the ophthalmoplegia market are Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Medline Industries Inc., Regeneron Pharmaceuticals Inc., Carl Zeiss AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Bayer AG, Santen Pharmaceutical Co. Ltd., Oculis Holding AG, Innovative Pharmaceuticals Pvt. Ltd., Clearside Biomedical Inc., Altacor Limited, Azura Ophthalmics Ltd., ViGeneron GmbH, Amritt Inc., GenSight Biologics SA, EyeBio Inc., Opthea Limited.
North America was the largest region in the ophthalmoplegia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ophthalmoplegia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ophthalmoplegia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ophthalmoplegia market consists of revenues earned by entities by providing services such as diagnosis and imaging services, neurological and ophthalmic evaluations, genetic testing and counselling, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmoplegia market also includes sales of eye patches and prisms, neuromuscular electrical stimulation (NMES) devices, corticosteroids, immunosuppressants, and botulinum toxin injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ophthalmoplegia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ophthalmoplegia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ophthalmoplegia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmoplegia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: External Opthalmoplegia; Internuclear Opthalmoplegia
2) By Treatment: Surgery; Drug Treatment
3) By End-User: Hospitals; Clinics; Ambulatory Clinics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Ophthalmoplegia Market Characteristics
3. Ophthalmoplegia Market Trends And Strategies
4. Ophthalmoplegia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Ophthalmoplegia Growth Analysis And Strategic Analysis Framework
5.1. Global Ophthalmoplegia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ophthalmoplegia Market Growth Rate Analysis
5.4. Global Ophthalmoplegia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ophthalmoplegia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ophthalmoplegia Total Addressable Market (TAM)
6. Ophthalmoplegia Market Segmentation
6.1. Global Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Opthalmoplegia
Internuclear Opthalmoplegia
6.2. Global Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgery
Drug Treatment
6.3. Global Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Clinics
6.4. Global Ophthalmoplegia Market, Sub-Segmentation Of External Ophthalmoplegia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.5. Global Ophthalmoplegia Market, Sub-Segmentation Of Internuclear Ophthalmoplegia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Unilateral Internuclear Ophthalmoplegia
Bilateral Internuclear Ophthalmoplegia
7. Ophthalmoplegia Market Regional And Country Analysis
7.1. Global Ophthalmoplegia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ophthalmoplegia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Ophthalmoplegia Market
8.1. Asia-Pacific Ophthalmoplegia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ophthalmoplegia Market
9.1. China Ophthalmoplegia Market Overview
9.2. China Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ophthalmoplegia Market
10.1. India Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ophthalmoplegia Market
11.1. Japan Ophthalmoplegia Market Overview
11.2. Japan Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ophthalmoplegia Market
12.1. Australia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ophthalmoplegia Market
13.1. Indonesia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ophthalmoplegia Market
14.1. South Korea Ophthalmoplegia Market Overview
14.2. South Korea Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ophthalmoplegia Market
15.1. Western Europe Ophthalmoplegia Market Overview
15.2. Western Europe Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ophthalmoplegia Market
16.1. UK Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ophthalmoplegia Market
17.1. Germany Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ophthalmoplegia Market
18.1. France Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ophthalmoplegia Market
19.1. Italy Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ophthalmoplegia Market
20.1. Spain Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ophthalmoplegia Market
21.1. Eastern Europe Ophthalmoplegia Market Overview
21.2. Eastern Europe Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ophthalmoplegia Market
22.1. Russia Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ophthalmoplegia Market
23.1. North America Ophthalmoplegia Market Overview
23.2. North America Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ophthalmoplegia Market
24.1. USA Ophthalmoplegia Market Overview
24.2. USA Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ophthalmoplegia Market
25.1. Canada Ophthalmoplegia Market Overview
25.2. Canada Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ophthalmoplegia Market
26.1. South America Ophthalmoplegia Market Overview
26.2. South America Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ophthalmoplegia Market
27.1. Brazil Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ophthalmoplegia Market
28.1. Middle East Ophthalmoplegia Market Overview
28.2. Middle East Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ophthalmoplegia Market
29.1. Africa Ophthalmoplegia Market Overview
29.2. Africa Ophthalmoplegia Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ophthalmoplegia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ophthalmoplegia Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ophthalmoplegia Market Competitive Landscape And Company Profiles
